Spain Drug Patent Inventor Report - 2011DrugPatentWatch
January 1, 2012
19 Pages - SKU: THBT6770959
More Regulation & Policy reports by DrugPatentWatch
Drug Patent Inventor Report 2012 by DrugPatentWatch
The Drug Patent Inventor Report profiles the individuals, US states, and countries leading pharmaceutical innovation.Using data on drugs approved from 2000 to 2009, thisreport provides ...
Drug Patent Challenge Report by DrugPatentWatch
The Drug Patent Challenge Report profiles the companies that successfully challenged pharmaceutical drugs patents.Using data on drugs approved from 2000 to 2009, this report provides ...
Denmark Drug Patent Inventor Report - 2011 by DrugPatentWatch
TheDenmark Drug Patent Inventor Reportprofiles Denmark-based inventors leading pharmaceutical innovation.Using data on drugs approved from 2000 to 2010, this report provides complete lists of: Top ...
China Drug Patent Inventor Report - 2011 Publication List by DrugPatentWatchSee all reports like this >>
TheChina Drug Patent Inventor Reportprofiles China-based inventors leading pharmaceutical innovation.Using data on drugs approved from 2000 to 2010, this report provides complete lists of: Top ...
More Spain Regulation & Policy reports
Spain Pharmaceutical Market Overview – Continued stagnation as generics and price cuts erode market value by Datamonitor
IntroductionThe market environment in Spain is extremely challenging, with cost containment measures introduced in 2010–12 contributing to an overall reduction in pharmaceutical spending. The changes ...
5EU: Pricing, Reimbursement and Regulatory Update by Datamonitor
IntroductionGovernments across the five major EU markets (France, Germany, Italy, Spain, and the UK) have been busy implementing regulatory, pricing, and reimbursement reforms in 2011. ...
Pharmaceutical Pricing and Reimbursement in Spain, 2008 by Decision ResourcesSee all reports like this >>
Introduction In recent years, Spain has rapidly increased its spending on healthcare, and pharmaceuticals account for a larger share of healthcare expenditures in Spain than ...
More Spain reports
D&B Country RiskLine Report: Spain by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Spain by Dun & Bradstreet Inc.See all reports like this >>
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
We can help you find what you need. Call us or write us:
Need help in your search?
Regulation & Policy Reports